Advertisement
Advertisement
ZLAB
Zai Lab Limited - ADR
25.64
USDSponsored
-0.37
-1.42%
Aug 24, 16:00 UTC -4
Closed
After-Market
25.39
-0.25
-0.96%
ZLAB Earnings Reports
Positive Surprise Ratio
ZLAB beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$110.80M
/-$0.05
Implied change from Q2 26 (Revenue/ EPS)
+4.23%
/--
Implied change from Q3 25 (Revenue/ EPS)
-3.95%
/+66.67%
Zai Lab Limited - ADR earnings per share and revenue
On Aug 06, 2026, ZLAB reported earnings of -0.05 USD per share (EPS) for Q2 26, beating the estimate of -0.06 USD, resulting in a 24.01% surprise. Revenue reached 106.31 million, compared to an expected 107.43 million, with a -1.04% difference. The market reacted with a +13.66% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.05 USD, with revenue projected to reach 110.80 million USD, implying an increase of 0.00% EPS, and increase of 4.23% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.35
Surprise
+198.38%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Alpha Cognition Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.40
Surprise
-0.05%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
PDS Biotechnology Corporation Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.18
Surprise
-35.75%
FAQ
What were Zai Lab Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Zai Lab Limited - ADR reported EPS of -$0.05, beating estimates by 24.01%, and revenue of $106.31M, -1.04% below expectations.
How did the market react to Zai Lab Limited - ADR's Q2 2026 earnings?
The stock price moved up 13.66%, changed from $18.37 before the earnings release to $20.88 the day after.
When is Zai Lab Limited - ADR expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Zai Lab Limited - ADR's next earnings report?
Based on --
analysts, Zai Lab Limited - ADR is expected to report EPS of -$0.05 and revenue of $110.80M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement